Hosp. Clinic de Barcelona — Barcelona

Public research footprint of Hosp. Clinic de Barcelona, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Multiple Myeloma · Leukemia, Myeloid, Acute · Non-Muscle Invasive Bladder Neoplasms · Lymphoma, Non-Hodgkin

Recently updated registry entries

NCT03145181 — Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in… (Active Not Recruiting)
NCT05850689 — Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major… (Recruiting)
NCT05049798 — A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hosp. Clinic de Barcelona?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.